Celyad Oncology SA
F:1C0S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celyad Oncology SA
F:1C0S
|
BE |
|
Grupo Aeroportuario del Centro Norte SAB de CV
BMV:OMAB
|
MX |
|
Arista Networks Inc
F:1170
|
US |
|
F
|
Fortune Brands Home & Security Inc
LSE:0IRN
|
US |
|
C
|
Charles Schwab Corp
XMUN:SWG
|
US |
|
T
|
Travelzoo
F:TXM1
|
US |
|
Bid Corporation Ltd
OTC:BDDDY
|
ZA |
|
W
|
Whirlpool Corp
BMV:WHR
|
US |
|
RENERGEN Ltd
ASX:RLT
|
ZA |
|
T
|
Titanium Transportation Group Inc
TSX:TTNM
|
CA |
|
TAT Technologies Ltd
NASDAQ:TATT
|
IL |
|
W
|
Wartsila Oyj Abp
OTC:WRTBY
|
FI |
|
Sinopec Oilfield Service Corp
F:YIZH
|
CN |
|
IAR Systems Group AB
OTC:IARGF
|
SE |
|
W
|
Wells Fargo & Co
F:NWT
|
US |
|
Sinopec Oilfield Service Corp
OTC:YZCFF
|
CN |
|
N
|
Nyocor Co Ltd
SSE:600821
|
CN |
|
Legend Power Systems Inc
F:XLE1
|
CA |
|
G
|
Global Health Clinics Ltd
F:L00
|
CA |
|
M
|
Mitsubishi UFJ Financial Group Inc
DUS:MFZ
|
JP |
|
A
|
Agilysys Inc
F:PS3
|
US |
Dividends
Dividend Yield
Celyad Oncology SA
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Celyad Oncology SA
1C0S have decreased by 0%.
Payout Ratio
Celyad Oncology SA
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 1C0S is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
1C0S Price
Celyad Oncology SA
| Average Annual Return | -30% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -99% |
| Market Capitalization | 12.9m EUR |
| Shares Outstanding | 22 594 000 |
| Percentage of Shares Shorted |
N/A
|
